ALEXANDRIA, Va. (September 14, 2021)—The National Home Infusion Association (NHIA) announced that in 2022 it will launch a new peer reviewed publication, Infusion Journal. This new scholarly journal will feature independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses and case studies. NHIA will publish Infusion Journal three times per year, and it will initially mail as a supplement to INFUSION magazine, NHIA’s flagship publication.
NHIA, through its 501(c)(3) affiliate National Home Infusion Foundation (NHIF), has renewed its focus on the importance of research and evidence-based practice for the past decade. NHIF has published several research studies resulting from the collection of industry-wide, standardized data on patient satisfaction, reasons for discontinuation of home infusion services, and experiences with administration of COVID-19 monoclonal antibodies. Infusion Journal will encourage individual clinicians to conduct independent research and submit the results for publication.
“Our provider organizations are operating in a unique and growing health care sector that is underrepresented in the academic-style publishing arena,” observes NHIA’s President and CEO Connie Sullivan, BSPharm. “With the publication of Infusion Journal, NHIA will make data-driven clinical and policy-related findings available to the many disciplines involved in delivering infusion therapies in a variety of settings.”
To learn more about submitting articles to Infusion Journal, visit infusionjournal.com.
